Moderator:Coy Stull, Of Counsel, Carlton Fields, PA,
Panelists:April Weisbruch, Partner, McDermott Will & Emery LLP
John Bateman, Counsel, Parker Poe Adams & Bernstein LLP
Christopher Bruno, Partner, McDermott Will & Emery LLP
Summary:
The program will cover recent developments in the Hatch-Waxman and BPCIA litigation and legislation, in particular, the Federal Circuit decisions in Amgen Inc et al v. Sanofi, GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc., Valeant Pharmaceuticals North America, LLC. et al v. Mylan Pharmaceuticals, Inc., as well as the Orange Book Transparency Act and the Purple Book Continuity Act.
Please join us for what will be an interesting and enlightening discussion.